Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Emyria Ltd ( (AU:EMD) ).
Emyria Limited has called an extraordinary general meeting for 1 May 2026 in West Perth, setting a record date of 29 April 2026 for shareholders eligible to vote. The meeting follows recent capital-raising activity and will allow investors to review and endorse key elements of the company’s latest financing structure.
Shareholders will be asked to ratify the prior issue of more than 133 million placement shares under ASX Listing Rules 7.1 and 7.1A, restoring the company’s placement capacity for future raisings. They will also vote on ratifying up to 10 million options issued to joint lead managers and a co-manager, which formalises the incentives for advisers and may affect future dilution for existing investors.
The most recent analyst rating on (AU:EMD) stock is a Sell with a A$0.04 price target. To see the full list of analyst forecasts on Emyria Ltd stock, see the AU:EMD Stock Forecast page.
More about Emyria Ltd
Emyria Limited is an Australian company whose shares are listed on the ASX. The company operates within the healthcare and life sciences investment landscape, raising capital through share placements and engaging lead managers to support its financing activities and shareholder base development.
Average Trading Volume: 1,355,833
Technical Sentiment Signal: Hold
Current Market Cap: A$37.91M
Find detailed analytics on EMD stock on TipRanks’ Stock Analysis page.

